Iris Clothings Ltd

The transcript does not mention any current or future plans for fundraising through debt or equity. Key points related to financials and capex include: - Capex target for FY24 is around INR 3 crores, focused on increasing installed capacity to about 35,000 pieces per day. - No discussion or indication of debt or equity fundraising during the call. - Management discussed margins, inventory, and operational performance but did not mention raising funds via equity or debt. - The company is focusing on organic growth through distribution expansion, product portfolio, and digital transformation. In summary, no new fundraising through debt or equity is reported or planned as per the information in the Q4 & FY23 earnings call transcript.

- For FY24, Iris Clothing Limited plans a capex of around INR 3 crores, focused on stitching and finishing. - This investment will increase the installed capacity to approximately 35,000 to 36,000 pieces per day, up from about 33,000 pieces per day in FY23. - The company consistently spends about INR 3 crores annually on capex to support manufacturing operations. - Strategic plans include launching new product categories such as undergarments in the near term. - The company aims to expand its manufacturing capability and product portfolio to support growth. - Digital transformation efforts continue, including development of B2B and D2C e-commerce platforms to improve market reach and working capital efficiency. - Retail expansion plans include opening own brick-and-mortar stores under the brand "DOREME" starting next quarter or shortly after.

- Full-year revenue for FY23 stood at INR113 crores, growing by 1.2% year on year despite low sell volumes due to reduced consumption. - Installed manufacturing capacity increased from 30,000 to 33,000 pieces per day in FY23; planned increase to around 35,000-36,000 pieces per day in FY24. - Expectation of improved EBITDA margins in FY24 due to price hikes and demand recovery. - Infantwear segment expected to grow from 7% to approximately 12% of revenue in the current year. - Online business and direct-to-consumer platform (doreme.in) are growth focuses, with digital marketing initiatives ongoing. - Expansion of distribution network domestically (including Tier 2 and 3 cities) and internationally (Middle East, Africa, West Asia). - Additional product launches planned including undergarments and Disney/Marvel licensed apparels expected to boost sales. - Capex target of around INR3 crores annually to support capacity expansion and product development.

- FY24 EBITDA margin expected around 20%-20.5%, improvement from 17.2% in FY23. - Net profit margin projected to be 10%+, up from 7.3% in FY23. - Revenue growth anticipated due to price hikes, demand recovery, and new product launches including Disney co-branded apparel and undergarments. - Capex of around INR 3 crores planned for FY24 to increase capacity to 35,000-36,000 pieces per day, supporting higher volumes. - Expansion in infantwear expected to increase revenue contribution from 7% to approximately 12% in FY24. - Digital transformation with B2B platform and D2C online platform expected to drive growth and improve working capital over the next 2-3 years. - Overall optimism about growth trajectory due to brand expansion, product diversification, and geographic reach in domestic and international markets.

The transcript does not explicitly mention the current or expected order book or pending orders for Iris Clothing Limited. However, the following related points provide some context on business levels and outlook: - Shipment of first batch of Disney licensed T-shirts has been dispatched, with phased launches of other Disney/Marvel products planned throughout the year. - Management mentioned good traction in new product lines like infant wear and accessories. - Capacity expansions underway, with installed capacity expected to increase to 35,000-36,000 pieces per day in FY24. - Management confident about demand recovery and margin improvement in FY24. - Capex of INR 3 crores targeted for FY24 to support increased capacity and new product launches. No specific figures or details on order book or pending orders are provided in the earnings call transcript.